Sahil Chopra
Direktor/Vorstandsmitglied bei Indapta Therapeutics, Inc.
Profil
Sahil Chopra is currently a Senior Associate at VVHC, based in San Francisco, where he helps to execute investments in biotech.
Sahil serves as a board observer for Indapta Therapeutics and previously served as a board observer for Elevation Oncology (NASDAQ: ELEV).
Prior to VVHC, Sahil was a venture fellow at FundRx and has experience in consulting for immunology-based startups, banks (equity research) and mid-sized biotech firms.
Sahil completed his PhD in immunology from Weill Cornell Graduate School (joint program at Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine) in New York in the lab of Dr. Laurie Glimcher (former Dean of Weill Cornell and the current President and CEO of Dana Farber Cancer Institute, Harvard University) and Dr. Juan Cubillos-Ruiz.
Aktive Positionen von Sahil Chopra
| Unternehmen | Position | Beginn |
|---|---|---|
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.01.2023 |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 01.02.2022 |
Ehemalige bekannte Positionen von Sahil Chopra
| Unternehmen | Position | Ende |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 01.10.2021 |
Ausbildung von Sahil Chopra
| Weill Cornell Graduate School of Medical Sciences | Graduate Degree |
| Maharshi Dayanand University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Finance |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Health Technology |
